CEBP Grants Frontiers in Basic Cancer Research
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

Cancer Epidemiology Biomarkers & Prevention 16, 2416, November 1, 2007. doi: 10.1158/1055-9965.EPI-07-0256
© 2007 American Association for Cancer Research

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vollset, S. E.
Right arrow Articles by González, C. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vollset, S. E.
Right arrow Articles by González, C. A.
Related Collections
Right arrow Epidemiology
Right arrow Epidemiology: Biomarkers
Right arrow Epidemiology: Molecular Epidemiology
Right arrow Risk Assessment: Biomarkers

The Association of Gastric Cancer Risk with Plasma Folate, Cobalamin, and Methylenetetrahydrofolate Reductase Polymorphisms in the European Prospective Investigation into Cancer and Nutrition

Stein Emil Vollset1,4, Jannicke Igland2, Mazda Jenab3, Åse Fredriksen1, Klaus Meyer1, Simone Eussen1, Håkon K. Gjessing4, Per Magne Ueland1, Guillem Pera5, Núria Sala6, Antonio Agudo5, Gabriel Capella6, Giuseppe Del Giudice7, Domenico Palli8, Heiner Boeing9, Cornelia Weikert9, H. Bas Bueno-de-Mesquita10, Fátima Carneiro11, Valeria Pala12, Paolo Vineis13,14, Rosario Tumino15, Salvatore Panico16, Göran Berglund17, Jonas Manjer18, Roger Stenling19, Göran Hallmans20, Carmen Martínez21, Miren Dorronsoro22, Aurelio Barricarte23, Carmen Navarro24, José R. Quirós25, Naomi Allen26, Timothy J. Key26, Sheila Bingham27, Jakob Linseisen28, Rudolf Kaaks28, Kim Overvad29, Anne Tjønneland30, Frederike L. Büchner10, Petra H.M. Peeters31, Mattijs E. Numans31, Françoise Clavel-Chapelon32, Marie-Christine Boutron-Ruault32, Antonia Trichopoulou33, Eiliv Lund34, Nadia Slimani3, Pietro Ferrari3, Elio Riboli13 and Carlos A. González5

1 LOCUS for Homocysteine and Related Vitamins, Institutes of Medicine and Public Health and Primary Health Care, University of Bergen, and Haukeland University Hospital; 2 UNIFOB-Helse, Bergen, Norway; 3 IARC, Lyon, France; 4 The Norwegian Institute of Public Health, Oslo, Norway; 5 Department of Epidemiology, IDIBELL-Catalan Institute of Oncology; 6 Translational Research Laboratory, IDIBELL-Catalan Institute of Oncology, Barcelona, Spain; 7 IRIS Research Center, Chiron-Vaccines, Siena, Italy; 8 Molecular and Nutritional Epidemiology Unit, Centro per lo Studio e la Prevenzione Oncologica, Scientific Institute of Tuscany, Florence, Italy; 9 Department of Epidemiology, German Institute of Human Nutrition, Potsdam-Rehbrücke, Germany; 10 Center for Nutrition and Health, National Institute for Public Health and the Environment, Bilthoven, the Netherlands; 11 Institute of Pathology and Molecular Immunology of the University of Porto and Medical Faculty/H.S. Joao, Porto, Portugal; 12 Nutritional Epidemiology Unit, National Cancer Institute, Milan, Italy; 13 Department of Epidemiology and Public Health, Imperial College, London, United Kingdom; 14 Department of Biomedical Science, University of Torino, Turin, Italy; 15 Cancer Registry Azienda Ospedaliera Civile-M.P. Arezzo, Ragusa, Italy; 16 Department of Clinical and Experimental Medicine, Federico II University, Naples, Italy; 17 Department of Medicine, Lund University; 18 Department of Surgery, University Hospital, Malmö, Sweden; 19 Department of Medical Biosciences, Pathology and 20 Department of Public Health and Clinical Medicine, Nutritional Research, Umeå University, Umeå, Sweden; 21 Andalusian School of Public Health, Granada, Spain; 22 Department of Public Health of Guipuzkoa, San Sebastian, Spain; 23 Public Health Institute, Navarra, Spain; 24 Department of Epidemiology, Health Council of Murcia, Murcia, Spain; 25 Public Health and Health Planning Directorate, Asturias, Spain (Dirección General de Salud Pública, Consejería de Salud y Servicios Sanitarios, Asturias, Spain); 26 Cancer Research UK, Epidemiology Unit, University of Oxford, Oxford, United Kingdom; 27 MRC Dunn Human Nutrition Unit and MRC Centre for Nutritional Epidemiology in Cancer Prevention and Survival, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom; 28 Division of Clinical Epidemiology, German Cancer Research Center, Heidelberg, Germany; 29 Department of Clinical Epidemiology, Aalborg Hospital, Aarhus University Hospital, Aalborg, Denmark; 30 Institute of Cancer Epidemiology, Danish Cancer Society, Copenhagen, Denmark; 31 Julius Center for Health Sciences and Primary Care, University Medical Center, Utrecht, the Netherlands; 32 Institut National de la Santé et de la Recherche Médicale, U521, Institut Gustave Roussy, Villejuif, France; 33 Department of Hygiene and Epidemiology, Medical School University of Athens, Athens, Greece; and 34 Institute of Community Medicine, University of Tromsø, Tromsø, Norway

Requests for reprints: Stein Emil Vollset, Institute of Public Health and Primary Health Care, University of Bergen, Kalfarveien 31, 5093 Bergen, Norway. E-mail: vollset{at}uib.no

Previous studies have shown inconsistent associations of folate intake and polymorphisms of the methylenetetrahydrofolate reductase (MTHFR) gene with gastric cancer risk. Our nested case-control study within the European Prospective Investigation into Cancer and Nutrition cohort is the first prospective study of blood folate levels and gastric cancer. Gastric cancer cases (n = 247) and controls (n = 631) were matched for study center, age, sex, and time of blood donation. Two common single nucleotide polymorphisms of the MTHFR gene were determined, as were plasma concentrations of folate, cobalamin (vitamin B12), total homocysteine, and methylmalonic acid (cobalamin deficiency marker) in prediagnostic plasma. Risk measures were calculated with conditional logistic regression. Although no relations were observed between plasma folate or total homocysteine concentrations and gastric cancer, we observed a trend toward lower risk of gastric cancer with increasing cobalamin concentrations (odds ratio, 0.79 per SD increase in cobalamin; P = 0.01). Further analyses showed that the inverse association between cobalamin and gastric cancer was confined to cancer cases with low pepsinogen A levels (marker of severe chronic atrophic gastritis) at the time of blood sampling. The 677 C->T MTHFR polymorphism was not associated with gastric cancer, but we observed an increased risk with the variant genotype of the 1298 A->C polymorphism (odds ratio, 1.47 for CC versus AA; P = 0.04). In conclusion, we found no evidence of a role of folate in gastric cancer etiology. However, we observed increased gastric cancer risk at low cobalamin levels that was most likely due to compromised cobalamin status in atrophic gastritis preceding gastric cancer. (Cancer Epidemiol Biomarkers Prev 2007;16(11):2416–24)




This article has been cited by other articles:


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
Q. Yang, R. M. Bostick, J.M. Friedman, and W. D. Flanders
Serum Folate and Cancer Mortality Among U.S. Adults: Findings from the Third National Health and Nutritional Examination Survey Linked Mortality File
Cancer Epidemiol. Biomarkers Prev., May 1, 2009; 18(5): 1439 - 1447.
[Abstract] [Full Text] [PDF]


Home page
Ann OncolHome page
C. Pelucchi, I. Tramacere, P. Bertuccio, A. Tavani, E. Negri, and C. La Vecchia
Dietary intake of selected micronutrients and gastric cancer risk: an Italian case-control study
Ann. Onc., January 1, 2009; 20(1): 160 - 165.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
K. Meyer, A. Fredriksen, and P. M. Ueland
MALDI-TOF MS Genotyping of Polymorphisms Related to 1-Carbon Metabolism Using Common and Mass-Modified Terminators
Clin. Chem., January 1, 2009; 55(1): 139 - 149.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2007 by the American Association for Cancer Research.